Author | Kenneth I. Kaitin

Articles

Opinion: Memo to von Eschenbach

Pharmaceutical Executive

Article

Often, post-approval marketing studies don't materialize because drug companies question their value. Independent review of the need for such studies would address pharma's concern that they may be warranted.